Citta Ospedaliera; Divisione Oncologia Medica

Avellino, Campania 83100

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR" — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed